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Alcohol Consumption is associated with Increased CEA Levels in Male Patients
with Stage IV Colorectal Cancer- A Single-Institution Retrospective Analysis
Abstract
Introduction: Alcohol use is an independent risk factor for liver metastasis, a major cause of morbidity
and mortality in colorectal cancer (CRC) patients. Serum CEA level is an established prognostic indicator
in CRC, yet the correlation with behavioral factors such as alcohol use remains to be defined. In a singlecenter review, we evaluated alcohol use, gender, and CEA levels in predicting advanced disease in CRC
patients.
Methods: Retrospective analysis of UNMC patients diagnosed with CRC as the primary cancer between
2012-2019, stages I-IV, and age >19 with documentation of alcohol use. Univariable statistics were
performed using Chi-Square and non-parametric tests. Associations between stage, gender, and alcohol
use (some vs. none) and the log-transformed CEA outcome (either initial or rate of change) were
assessed using linear regressions.
Results: Alcohol use was found to be reported in 333 of 1243 CRC patients. The cohort was comprised of
192 male and 141 female subjects. Elevated CEA levels at CRC diagnosis were associated with increased
all-cause mortality (33.0% for CEA > 3.4ng/ml vs 10.4% for CEA < 3.4ng/ml). Model analysis found that
stage IV male alcohol users showed an increase in serial CEA levels compared to males who did not use
alcohol, but this pattern was not observed among stage IV females.
Conclusions: Males with a history of alcohol use may be at risk for advanced CRC disease suggesting the
utility of serial serum CEA monitoring in these patients. A detailed alcohol use history should be obtained
in all patients with CRC as it has prognostic value and may allow for early intervention. This analysis was
limited by missing alcohol use data for the majority (73.2%) of CRC patients evaluated. A prospective
study is warranted to define the implications of alcohol use and risk of CRC liver metastasis.
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Abstract
Introduction: Alcohol use is an independent
risk factor for liver metastasis, a major cause
of morbidity and mortality in colorectal
cancer (CRC) patients. Serum CEA level is
an established prognostic indicator in CRC,
yet the correlation with behavioral factors
VXFKDVDOFRKROXVHUHPDLQVWREHGH¿QHG,Q
a single-center review, we evaluated alcohol
use, gender, and CEA levels in predicting
advanced disease in CRC patients.
Methods: Retrospective analysis of UNMC
patients diagnosed with CRC as the primary
FDQFHUEHWZHHQVWDJHV,,9
and age >19 with documentation of alcohol
use. Univariable statistics were performed
using Chi-Square and non-parametric tests.
Associations between stage, gender, and
alcohol use (some vs. none) and the logtransformed CEA outcome (either initial or
rate of change) were assessed using linear
regressions.
Results: Alcohol use was found to be
reported in 333 of 1243 CRC patients. The
cohort was comprised of 192 male and 141
female subjects. Elevated CEA levels at CRC
diagnosis were associated with increased
all-cause mortality (33.0% for CEA > 3.4ng/
ml vs 10.4% for CEA < 3.4ng/ml). Model
DQDO\VLVIRXQGWKDWVWDJH,9PDOHDOFRKRO
users showed an increase in serial CEA levels
compared to males who did not use alcohol,
but this pattern was not observed among stage
,9IHPDOHV
Conclusions: Males with a history of alcohol
use may be at risk for advanced CRC disease
suggesting the utility of serial serum CEA
monitoring in these patients. A detailed
alcohol use history should be obtained in all
patients with CRC as it has prognostic value
and may allow for early intervention. This
analysis was limited by missing alcohol use
data for the majority (73.2%) of CRC patients
evaluated. A prospective study is warranted to
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GH¿QHWKHLPSOLFDWLRQVRIDOFRKROXVHDQGULVN
of CRC liver metastasis.

Introduction
Colorectal cancer (CRC) is the 3rd most
common cancer worldwide, and in the U.S.
alone, accounts for over 50,000 deaths
annually.1 CRC mortality is primarily due to
the development of colorectal liver metastasis
(CRLM).2-3 Over 50% of CRC patients will
either present with synchronous disease or
later develop metachronous liver metastases
during their disease course.4 Despite
advancements in surgical interventions and
chemotherapeutics, CRLM is associated
with poorer outcomes, emphasizing the
QHHGWRGH¿QHPHFKDQLVPVDQGPHDVXUHVWR
monitor the spread of disease. While there are
continued extensive efforts to optimize CRC
screening, we are lacking an understanding
of methods to identify patients at risk for
development of CRLM. This is especially
evident in patient populations with an alcohol
use history that may correlate with advanced
CRC disease and CRLM-associated mortality.
,QWKH86WKH¿YH\HDUUHODWLYHVXUYLYDOIRU
SDWLHQWVZLWKVWDJH,,,,&5&YDULHVEHWZHHQ
71-90% whereas those with metastatic liver
disease have 14% survival.5 This profound
decrease in survival rates demonstrates
the necessity to identify patients at risk for
development of metastatic disease, especially
CRLM because the liver is the predominant
site of CRC spread. Alcohol abuse is known
to contribute to 6% of the World deaths
with approximately 12% of those deaths
being associated with alcohol-related
carcinogenesis. Other lifestyle habits such
as smoking and consumption of red meat are
also associated with CRC burden.6-8 However,
alcohol consumption, in particular, has been
LGHQWL¿HGDVDQLQGHSHQGHQWULVNIDFWRURI
CRLM and a factor associated with poorer
prognosis of CRC patients.8-10 Alcohol use
FRUUHODWHVZLWKLQFUHDVHG&5/0LGHQWL¿HGDW

initial CRC diagnosis as well as with hepatic
metastases that occur throughout the disease
course.10-11 Preclinical studies have shown
that the alcohol-injured liver is susceptible
to developing CRLM earlier and to a greater
extent compared to healthy liver.12-16
Clinical assessments have shown that CRC
patients with an alcohol use history often
require intensive follow-up due to reduced
liver function, unresectable hepatic lesions,
and poor survival rates.6, 17-18 However,
few reports exist concerning alcohol and
CRLM risk in the U.S. indicating the need
IRUUHVHDUFKGH¿QLQJWKHUROHRIDOFRKRO
consumption in CRC burden. Moreover,
recent studies indicate an alarming increase
in the rate of morbidity and mortality from
alcohol use disorders and related diseases in
the U.S.19 This is especially evident as alcohol
use patterns such as heavy and episodic
binge drinking may have a profound impact
on disease burden and healthcare costs. As a
result, there is a call for focused public health
strategies to address alcohol misuse and to
characterize the role of alcohol consumption
as a predisposing factor to CRLM in high-risk
populations.
The Midwest region of the US has one of the
highest incidence rates of CRC as well as
heavy and binge drinking prevalence.1, 20-21
The aberrant use of alcohol is estimated
to contribute to the higher incidence of
CRC with evidence indicating that heavy
drinking increases the risk of CRC mortality.6
Additionally, the elevated risk of poor
outcomes of CRC appear higher for men
compared to women at similar levels of
alcohol exposure. The male gender has also
been established as an independent risk factor
for incidence of CRLM.4, 22-23 Altogether, the
level of alcohol consumption prior to CRC
GLDJQRVLVLVFRQVLGHUHGDVLJQL¿FDQWULVN
factor not only for cancer development but for
poor outcomes as well. The geographic and
VH[VSHFL¿FULVNVDVVRFLDWHGZLWKGULQNLQJ
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QHHGWREHFRQ¿UPHGE\IXUWKHUUHVHDUFKDQG
PD\EHEHQH¿WHGE\WKHFKDUDFWHUL]DWLRQRI
combined assessments of cancer biomarkers
and alcohol consumption.
The potential of serum carcinoembryonic
antigen (CEA) as a measure of advanced CRC
has been demonstrated in both preclinical
and clinical studies.11, 14, 24-25 As a result,
serum CEA levels are routinely monitored
in CRC patients and it is well established
that elevated levels correlate with advanced
disease.24-25,PSRUWDQWO\&($OHYHOVZHUH
found to be increased in >80% of patients
with distant metastasis with serial CEA
measures used as a detection method for
CRLM.24 However, the monitoring of CEA
as an exclusive biomarker has been longdebated in that 30-40% of CRC patients at
initial diagnosis do not have elevated serum
CEA values.26 Moreover, it is not known if
gender differences exist for serum CEA levels
in relationship to advanced CRC disease.
Thus, current research efforts are evaluating
the role of combination measures of serum
biomarkers, biochemical parameters, and
lifestyle habits for better follow-up and early
LGHQWL¿FDWLRQRI&5&SDWLHQWVDWKLJKULVN
IRUWKHGHYHORSPHQWRIOLYHUPHWDVWDVLV,Q
this single-institution retrospective study, we
evaluated the associations of gender, alcohol
use, and stage with CEA levels in CRC
patients at the University of Nebraska Medical
Center (UNMC). We hypothesized that the
combination of these variables may be utilized
to identify at-risk populations for CRLM in a
region that has a high incidence of CRC and
alcohol use disorders.

Methods
Patient Population: We performed a
retrospective analysis of UNMC patients
diagnosed with CRC between 2012-2019.
Data were obtained from the UNMC clinical
data warehouse (CDW), an i2b2-based
data repository (https://www.i2b2.org/),
internally referred to as CRANE (Clinical
Research Analytics Environment). The i2b2
data is populated using information from
the Electronic Medical Record (EMR). The
inclusion criteria included CRC as the primary
FDQFHU1$$&&5VWDJH VWDJHV,,9 DJH
>19; and treatment at UNMC. The data
extracted included gender; history of alcohol
use, liver enzymes, serum CEA, and date
of death or last follow-up. This study was
UHYLHZHGDQGH[HPSWHGE\RXU,QVWLWXWLRQDO
Review Board.
Data Characteristics and Statistical
Analysis: A population of 1,243 CRC patients
LQDOOVWDJHV ,,9 ZDVLGHQWL¿HGLQWKH
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CRANE database. Only twenty-seven percent
of the total CRC patients had a documented
alcohol use history and were included
LQWKH¿QDODQDO\VLV'LIIHUHQFHVLQ&($
between subgroups of variables of interest
were assessed using Kruskal-Wallis tests,
and Wilcoxon Rank Sum tests for post-hoc
pairwise comparisons, or Chi-Square tests
when CEA was dichotomized (i.e., Low: CEA
< 3.4; High: CEA >= 3.4). For modeling,
initial CEA values were log transformed due
WRVLJQL¿FDQWVNHZQHVVLQWKHGDWD7RDVVHVV
change in CEA over time, the difference in
ORJ&($YDOXHV ORJ ¿QDOB&($ ±ORJ LQLWLDOB
CEA)) were divided by the length of follow
up, to give the average difference in log
CEA values per year. For both log of initial
CEA value and average annual change in
the log values of CEA as outcomes, a triple
interaction between stage, gender, and alcohol
use was assessed using linear regression
models, which adjusted for relevant lower
order interactions and main effects, as well
as initial log CEA for the change model only.
$VLJQL¿FDQWWULSOHLQWHUDFWLRQZDVIXUWKHU
investigated by assessing gender by alcohol
use interactions in separate models, one for
HDFKRIWKHWKUHHWXPRUVWDJHV ,,,,,,DQG
,9 6LJQL¿FDQWWZRZD\LQWHUDFWLRQVRU
main effects were assessed with Bonferroni
or Tukey’s post-hoc adjusted pairwise
comparisons, respectively. All analyses were
performed using SAS software version 9.4
6$6,QVWLWXWH,QF&DU\1& 

Results
Patient Characteristics: The patient
population evaluated in this study is shown in
)LJ$WRWDORISDWLHQWVZHUHLGHQWL¿HG

in the CRANE database as CRC patients of
all stages at UNMC between the years of
2012-2019. Three hundred and thirty-three
patients (26.7%) had information on alcohol
use (dichotomized as either no or some use)
that was recorded in the EMR. This cohort
evaluated was comprised of 192 male and
141 female subjects. Alcohol use did not
VLJQL¿FDQWO\GLIIHUDFURVVWKHWXPRUVWDJHV
DVVKRZQLQ7DEOH+RZHYHUVLJQL¿FDQWO\
fewer females reported alcohol use (27.7%)
compared to males (44.3%), p= 0.002.
Analysis of Alcohol Use and Serum CEA
levels: A linear regression analysis of the
log of serum CEA levels recorded near or at
the date of CRC diagnosis (initial CEA) is
represented in Fig. 2. The triple interaction
between stage, gender, and alcohol use was
QRWVLJQL¿FDQW S  +RZHYHUWKHPDLQ
HIIHFWRIVWDJHZDVVLJQL¿FDQWZKHUHLQLWLDO
serum CEA values (i.e., at time of CRC
GLDJQRVLV ZHUHIRXQGWREHVLJQL¿FDQWO\
LQFUHDVHGLQ6WDJH,9FRPSDUHGWRWKH6WDJHV
, S DQG6WDJHV,,,,, S 
as expected.
The utility of CEA measures as a prognostic
indicator of advanced disease and likely
CRLM is further emphasized by the analysis
of mortality and the initial recorded measure
of CEA in the patient cohort (Fig. 3). The
data indicate that elevated measures of
initial serum CEA levels are associated with
increased all-cause mortality (33.0% for CEA
> 3.4ng/ml vs 10.4% for CEA < 3.4ng/ml, p <
0.0001). Finally, an assessment of the yearly
change in log serum CEA values over time
GHPRQVWUDWHGDVLJQL¿FDQWWULSOHLQWHUDFWLRQ
between gender, stage, and alcohol use
(p=0.01). To further assess this relationship,

CRC patients (Stage I – V)
UNMC 2012 – 2019
(n=1234)
910 records exluded:
Missing alcohol-use data
Records screened
(n=333)

Male
(n=192)

Female
(n=141)

Figure 1. Flow diagram of the single-institution retrospective analysis of colorectal cancer patients with
alcohol-use data.
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the gender by alcohol two-way interaction
was assessed in separate models, one for each
stage. This interaction between gender and
DOFRKROXVHZDVRQO\VLJQL¿FDQWLQWKH6WDJH
,9SDWLHQWPRGHO S  :KLOHWKHUHZDV
QRVLJQL¿FDQWGLIIHUHQFHLQWKHUDWHRIFKDQJH
in log CEA between the two alcohol use
JURXSVDPRQJ6WDJH,9ZRPHQ S  
men in this stage who used alcohol had a
VLJQL¿FDQWO\KLJKHUUDWHRIFKDQJHLQORJ&($
than men who did not (p = 0.02) (Fig. 4).

Table 1.
Patient Characteristics, Alcohol use
(n)

Alcohol use
(some)

Alcohol use
(none)

Total CRC patients with alcohol use documented

333

124

209

Sex (% of total)
Male
Female

192
141

85 (44.3%)
39 (27.7%)

107 (55.7%)
102 (72.3%)

Stage (% of total, 13 missing)
I
II/III
IV

119
97
104

50 (42.0%)
36 (37.1%)
33 (31.7%)

69 (58.0%)
61 (62.9%)
71 (68.3%)

P-value

0.002

0.28

'LVFXVVLRQ

Recent studies indicate an alarming increased
rate of morbidity and mortality from alcohol
use disorders in the U.S. with the call for
focused public health strategies to address this
serious situation.6, 18-197KH1DWLRQDO,QVWLWXWH
RQ$OFRKRO$EXVHDQG$OFRKROLVP 1,$$$ 
has recommended that patients should be

Alive

Gender = Female

Gender = Male

8

6
Log of Initial CEA

Alcohol intake is a well-established risk factor
for primary CRC.27-28 Alcohol consumption
has also been shown to be an independent
risk factor of CRLM and poorer prognosis
of CRC patients.9-10, 18 The current literature
supports that alcohol creates a hepatic
microenvironment susceptible to tumor cell
seeding and growth.13-15, 29 However, few
reports exist concerning alcohol and CRLM
ULVNLQWKH866SHFL¿FDOO\WKHUHLVDSDXFLW\
of data in Midwest states such as Nebraska
that report high rates of alcohol use disorders
and risk of colorectal cancers1, 20-21 which
prompted this retrospective analysis of alcohol
use in CRC patients treated at the University
of Nebraska Medical Center.

4

2

0

I

II/III

IV

I

II/III

IV

NAACCR Stage
Alcohol

None

Some

Figure 2. Triple interaction between stage, gender, alcohol use (none vs some) and initial CEA values
UHFRUGHGLQFRORUHFWDOFDQFHUSDWLHQWV6WDJH,9KDGVLJQL¿FDQWO\KLJKHUORJLQLWLDO&($YDOXHVWKDQ
the other two stage groups (p<0.0001). NAACCR, North American Association of Central Cancer
Registries Stages I, II/III and IV.

Gender = Female

Deceased

Gender = Male

15

Average Change in log CEA per Year

Proportion (%)

10

5

0

<3.4

10

5

0

-5

>3.4

Serum CEA (ng/ml)

I

II/III

IV

I

II/III

IV

NAACCR Stage

Figure 3. CRC mortality in relationship to
initial serum CEA values. The percentage of
CRC patients (alive or deceased) compared
to the serum CEA levels obtained at initial visit
following colorectal cancer diagnosis.
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Alcohol

None

Some

Figure 4.$YHUDJHFKDQJHLQORJ&($SHU\HDUVWUDWL¿HGE\JHQGHUDQGVWDJH 1$$&&51RUWK
$PHULFDQ$VVRFLDWLRQRI&HQWUDO&DQFHU5HJLVWULHV6WDJHV,,,,,,DQG,9 $VLJQL¿FDQWLQWHUDFWLRQZDV
observed between gender and alcohol use in Stage IV male patients (p=0.02).
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questioned about the pattern of alcohol
consumption in addition to the number of
drinks consumed.30 At UNMC, the Electronic
Medical Record (EMR) alcohol history
includes frequency of alcohol use, drinks per
occasion, and type of alcohol (wine, beer,
liquor). However, questions are lacking for
the presence of binge episodes and prior
consumption patterns. Further, a review of
the EMR data at our institution indicates that
alcohol use data is not recorded in discrete
GDWD¿HOGVIRUWKHPDMRULW\RISDWLHQWV:KLOH
some EMR records contain physician notes
concerning alcohol consumption, this data
LVLQFRQVLVWHQWDQGYDULDEOHLQFRQWHQW,Q
agreement with this review, the current
retrospective analysis determined that only
RISDWLHQWUHFRUGVLGHQWL¿HGIRULQFOXVLRQ
were found to have alcohol use information
in the i2B2 repository. Additionally, the
majority of records reporting alcohol use were
not complete in relation to number of drinks
and type of alcohol consumed. As a result,
this study was only able to report alcohol
use as none or some alcohol consumed. This
limitation associated with poor documentation
of alcohol use at UNMC is also observed
as a widespread problem seen in across
institutions worldwide; several analyses have
demonstrated that alcohol use history and
diagnoses of alcohol use disorder are greatly
under documented in the EMR.31-33 This is a
major concern as alcohol use data could prove
to be meaningful in the investigations of
several disease processes, including colorectal
cancer.
Despite the limitation of missing alcohol use
data, the relationship of alcohol use history,
CRC stage, and tumor marker measures was
assessed in a cohort of 333 CRC patients.
The tumor marker studied was CEA, a
glycoprotein of the immunoglobulin gene
family that codes for several tumorigenic
adhesion proteins.34 CEA serum measures
have proven to be a useful marker for CRC
ZLWKDVLJQL¿FDQWEHQH¿WIRXQGIRUWKH
assessment of prognosis and liver metastasis.35
Studies indicate that patients with high
preoperative CEA serum concentrations
(>5 ng/ml) have worse outcomes as well as
disease recurrence.35-37,PSRUWDQWO\&($
OHYHOVDUHVLJQL¿FDQWO\HOHYDWHGLQSDWLHQWV
with distant metastasis and the measure of
serial CEA levels over time is used as an
accurate detection method for CRLM.17, 24
The results of our retrospective analysis are
consistent with reports for the use of CEA
as a marker for advanced disease.26, 38 CEA
OHYHOVLQFUHDVHGVLJQL¿FDQWO\ZLWKWXPRUVWDJH
and mortality correlated with elevated serum
&($OHYHOV+RZHYHUWKHFOLQLFDOVLJQL¿FDQFH
KDVQRWEHHQGH¿QHGIRUWKHPRQLWRULQJRI
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initial CEA values compared to serial CEA
measures in relationship to behavioral and
environmental factors such as alcohol use.
Furthermore, it is unclear if CEA levels
differ between men and women and what
role a history of alcohol consumption might
play. Our data indicates that initial, likely
SUHRSHUDWLYH&($YDOXHVDUHVLJQL¿FDQWO\
KLJKHUZKHQFRPSDULQJSDWLHQWVLQVWDJH,9
WRVWDJH,7KLVLVFRQVLVWHQWZLWKRWKHUVWXGLHV
DQGWKHZHOOGH¿QHGUROHRI&($LQSUHGLFWLQJ
advanced disease stage (i.e. CRLM) with
minimal increases in CEA levels seen after
initial diagnosis in early disease stages (i.e.
VWDJH, 24, 26, 38 Further, in this study with
limited alcohol use data, we were not able to
show an association between alcohol use and
initial CEA serum values during any stage of
CRC disease. Future analyses are needed to
determine if such a relationship exists.
With respect to gender differences, this
study indicates a potential role of alcohol
use and serial CEA values in males with
advanced CRC disease. This is clinically
relevant as the incidence and mortality of
colorectal cancer is known to be higher in
males.1, 39 Several retrospective, populationbased studies have also found male gender
to be a risk factor for both synchronous and
metachronous liver metastases.4, 22-23 However,
WKHUHDUHQRJHQGHUVSHFL¿FPHFKDQLVPV
for CRC diagnosis or monitoring based on
current society guidelines. This includes
initial screening for CRC and surveillance
SURWRFROVLQSDWLHQWVZLWKVWDJH,,DQG,,,
disease following resection.35, 40 The present
analysis found that male alcohol users with
VWDJH,9GLVHDVHVKRZHGDJUHDWHULQFUHDVHLQ
serial CEA levels than males who did not use
alcohol, a pattern that was not seen in stage
,9IHPDOHV7KHFXUUHQWOLWHUDWXUHVXSSRUWV
that male sex, alcohol use, and elevated CEA
levels are each independent risk factors for
the presence of metastatic liver disease. Thus,
males with a history of alcohol use should
be recognized as a high-risk population
for metastatic involvement and serial CEA
monitoring may have increased utility in these
patients.
,QVXPPDU\LQWKLVVWXG\DOFRKROXVHZDV
associated with increased average annual
FKDQJHLQ&($DPRQJVWDJH,9PDOHVDWOHDVW
in the small subset of patients where alcohol
use was documented. Considering the growing
burden of alcohol related disease, further
investigation regarding the implications of
alcohol use on development of CRLM may
be clinically meaningful and demonstrate the
importance of obtaining alcohol use data in
CRC patients. Given the substantial mortality
associated with CRLM, research efforts are

needed to focus on identifying vulnerable
patients. A detailed alcohol use history should
be obtained in all patients with CRC as it has
prognostic value. Our retrospective analysis
was limited by missing alcohol use data for
a majority of patients treated for CRC. A
prospective study is warranted for a better
XQGHUVWDQGLQJDQGGH¿QLWLYHFRQFOXVLRQVZLWK
regards to the implications of alcohol use on
liver metastases in CRC. 
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